Peer Review History
| Original SubmissionMay 18, 2023 |
|---|
|
Dear prof Alon, Thank you very much for submitting your manuscript "Major depressive disorder and bistability in an HPA-CNS toggle switch" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, James R. Faeder Academic Editor PLOS Computational Biology Pedro Mendes Section Editor PLOS Computational Biology *********************** A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: "Major depressive disorder and bistability in an HPA-CNS toggle switch" (PCOMPBIOL-D-23-00795) by prof Uri Alon and colleagues submitted to PLOS Computational Biology is a well written and important paper continuing earlier contributions by the same authors. Overall, the core part does only require minor changes whereas the Method section and especially the presentation of the mathematical model and the analysis of this needs extensive work. P.3 Results has a subsection named ‘A minimal model of the HPA-CNS toggle switch’ but in the Method section this is denoted the MDD model. You need to decide upon a single name! Despite your choice an appropriate and more descriptive heading could be ‘A toggle switch model of the HPA-CNS system’ (In the text the ‘minimal model’ feature is mentioned). P.3, l.-5 (meaning line 5 from bottom of page 3). I suggest substituting the word ‘described’ by ‘understood’. P.4 and throughout the paper, the imprecise and mathematically misleading term ‘steady state’ is used for ‘quasi-steady state’ (which could be abbreviated QSS). Please correct this throughout the text. P.4 , l.-6 ‘Kd’ is not defined. You may explain it in words. P.4, l.-4 It is not clear to the readers what ‘our model’ is!!!? P.5, Figure 1. Remove the vector field or make it more visible and complete (it appears sparce on the phase plane). P.6 Figure 1 caption. It is not clear how C) and D) actually are made, state if C) and D) correspond to high and low u. P.8, Figure 2. Strange idea to change colors compared to figure 1 (this is also the case for figure 4). Please unify. P.12, l.10 I suggest interchanging the word ‘minimal’ with ‘simple’. P. 14, l.2 You refer to nicely to Karin et al. However, the equations (1-3) looked very much like some I saw year before this reference. Thus, I looked it up and to me it seems like Karin et al is inspired by Bangsgaard & Ottesen (2017) Patient specific modeling of the HPA axis related to clinical diagnosis of depression. Math. Biosciences, 287. The authors also have a reduction like the one your do leading to (4-6). I think it would be suitable to refer to this paper. P.14, l.3 Put in bio-refs to support the claim or state that it is an assumption. P.14, eq. (1) Can you provide the reader with a bio-reference saying that MR and GR act multiplicatively? If not emphasize that this is an assumption. P.14, l.12-13. Are the expressions for MR(x_3) and GR(x_3) assumed or are these coming from data of some kinds? P.14, l.16. I think you need to be specific about assuming GR=1 and MR=x_3 to arrive with the reduced system (4-6). Likewise, you should emphasize that these are only good approximations for K_MR<<x_3<<k_gr>P. 14, l.21-22. Why the choice x_1 as growth factor for P and x2 for A? I would imagine that the hormone produced generates the growth, meaning that it should be x_ and x_3 respectively (this is common in many similar models). Give a bio-reference for this or emphasize these a (strange) assumptions! P. 14, l.-3 ‘to a good approximation’ compared to what? Maybe just write ‘approximately’? P.14, l.-1-P.15, l.2. I think this is pseudo modeling, since you are really modeling the common MR and GR inhibition as a step function? P.14-P.16 You may use the terms fast QSS and slow QSS consistently throughout this section! P.15, eq (9) First term on the right-hand side is really alpha-beta*theta(x_3>T) for suitable choices of positive beta<alpha. complication="" reciprocal="" so="" the="" why="">P.15, l.12 Is there an ‘of’ too much? P.15, l.17 ‘normalize’ do you mean \\tilde{x}_1=x_1/x_st, etc. and then renaming \\tilde{x}_1 as x_1 etc.? P.15, l.17-23. Is sloppy hand-waving / non-rigid and intuitive. Either that should be crystal clear or done properly e.g., does a QSS approximation require a stability analysis! P.16, l.3-6. This is not rigid but merely an illustration. P.16, eq. (18) Should the power 1/2 be the power 2? p.16, l. 12 ‘We’ after the period. P.16, l.13 Pst proportional to GR(x_3), but earlier you did assume GR(x_3)=1! P.16. After reading the section I still do not know what your model exactly is. Please state the resulting model uniquely! P.16. Add a table with all parameter values used.</alpha.></x_3<<k_gr> Reviewer #2: Review of Mizrachi et al, Major depressive disorder and bistability in an HPA-CNS toggle switch This paper addresses the origin of slow (weeks long timescale) dynamics of major depressive disorder using a minimal mathematical model and dynamical systems approaches. The model focuses on the interaction between the hypothalamus-pituitary-adrenal axis (HPA) and the central nervous system (CNS), and specifically incorporates the important but overlooked phenomena by which activation can control hormone gland sizes. The authors focus on the role of mutual inhibition between CNS and HPA activity, the latter mediated by glucocorticoids. Overall this work beautifully exemplifies ability of carefully crafted simplified dynamical models to provide powerful insights into the behavior of complex biological systems. It suggests an intriguing mechanism that explains how different setpoints in individuals can produce distinct (bistable vs. monostable) dynamics, how hysteretic effects can lead to extended timescales, and how specific disease-relevant perturbations could impact system dynamics. I anticipate it will have a major impact in the field of systems psychiatry, and will be of broader interest to researchers in systems biology, systems medicine, and psychiatry more generally. Given the increasing awareness and incidence of depression, especially among teens, I believe this work is also timely and potentially of interest beyond the academic and medical communities. The paper is beautifully and clearly written. I support acceptance in its current form. However, below I suggest a few minor comments the authors may wish to consider. Minor comments: • Cosmetic: Some of the figures have oddly compressed fonts, or somewhat fuzzy (low resolution) graphics, possibly reflecting an issue with the image compression. • It would be helpful to understand which parameters, if any, have the strongest impact on the qualitative predictions. • The authors may wish to consider making an animation of the nullcline analysis in which the reader could directly see how the nullclines and the system state “move” during various perturbations discussed in the text and, e.g. in Figure 2. Reviewer #3: This is a very important study that can help inform the treatment modalities for major depressive disorders, which afflict millions of people worldwide. By focusing on the HPA axis, which has a well documented role in MDD, the authors develop a mathematical model that describes the consequence of the HPA axis design (with two negative feedbacks and the resulting toggle switch) and importantly explain the requirement for long time scale of treatment to produce therapeutic effects. Although the study intentionally focused on one aspect of a complex problem, it provides valuable insights into the dynamics of HPA axis and explain previously poorly understood characteristics of MDD (requirement for prolonged stress) and its treatment (requirement for prolonged use of certain classes of anti-depressants). I think overall this is a very valuable contribution with original insights that would benefit the community. ********** Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No: I could find any aailable code Reviewer #2: Yes Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols References: Review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. |
| Revision 1 |
|
Dear prof Alon, We are pleased to inform you that your manuscript 'Major depressive disorder and bistability in an HPA-CNS toggle switch' has been provisionally accepted for publication in PLOS Computational Biology. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please also note that Reviewer 1 has noted a few instances of formatting errors or missing elements that need to be corrected. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. Best regards, James R. Faeder Academic Editor PLOS Computational Biology Pedro Mendes Section Editor PLOS Computational Biology *********************************************************** Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The manus is a litle sloppy and need some care in the next phase. This regard many references without authors (internet links appear) and some phrases in the text e.g. "parameters xxx.”" at page 24 ********** Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Johnny T. Ottesen |
| Formally Accepted |
|
PCOMPBIOL-D-23-00795R1 Major depressive disorder and bistability in an HPA-CNS toggle switch Dear Dr Alon, I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! With kind regards, Judit Kozma PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .